Herbalife Board Approves Share Buyback Programme of up to $250 Million
Herbalife's board has cleared a repurchase authorisation of up to $250 million in common shares, valid for three years. The move follows four consecutive quarters of year-on-year net sales growth at the nutrition group.
A three-year authorisation
Herbalife's board of directors has approved a share repurchase programme of up to $250 million. The authorisation runs for three years and allows the company to buy back its own common shares whenever management and the board judge such purchases to be an attractive use of capital.
The company frames the decision as an expression of confidence in its business strategy, its financial outlook and its ability to generate sustainable free cash flow. Chief Financial Officer John DeSimone said Herbalife has sufficient financial flexibility to invest in the operating business, maintain a solid balance sheet and return capital to shareholders at the same time.
The new authorisation replaces a considerably larger predecessor. A previous $1.5 billion repurchase programme expired in 2024, with a significant portion of it left unused — a detail that puts the scale of the fresh mandate into perspective.
Capital allocation framework
Herbalife stresses that its approach to capital allocation remains balanced. The stated priorities are investing in organic growth, pursuing strategic opportunities, preserving financial flexibility and returning excess capital to shareholders.
Buybacks, in other words, are positioned as one instrument among several rather than the centrepiece of the company's financial policy. The authorisation creates optionality over a three-year window without committing the company to a fixed pace of repurchases.
Four quarters of top-line growth
The announcement comes against a backdrop of improving reported figures. In the second quarter of 2026, Herbalife posted net sales of approximately $1.327 billion, up 5.4% on the same period a year earlier. Adjusted for currency effects, growth came in at 5.8%. It was the fourth consecutive quarter in which the company's net sales increased year on year.
For the first six months of 2026, net sales reached $2.644 billion, compared with $2.481 billion in the prior-year period. That represents an increase of 6.6%, or 5.6% excluding currency effects.
At the end of August 2026, Herbalife confirmed its guidance for the third quarter and for the full year 2026, continuing to expect growth on both a reported and a currency-neutral basis. Should that trajectory hold, 2026 would be the first year in which the company's net sales exceed $5 billion.
Advertisement
